Anti-cure impact of Errant EU patent decision on hESC - The Niche
There has been concern for months about the direction that the European Union was heading in regards to intellectual property (IP) rights and stem cells. Now, a definitive decision banning embryonic stem cell (ESC)-based patents by the EU Court has [...]